Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publicationmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentationmore...
The company reported standalone net profit of Rs 1.53 crore for the quarter ended December 31 2025 as compared to Rs 1.74 crore in the same ...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Resignation of Mr Mohith Kumar Khandelwal as Company Secretary & Complian...more...
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange the financial results for the period ended December 31 2025.more...
As of December 2025 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi ...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Credit Ratingmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Investment in wholly owned subsidiarymore...
The company reported standalone net profit of Rs 3.26 crore for the quarter ended September 30 2025 as compared to Rs 1.66 crore in the same period l...more...
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange the financial results for the period ended September 30 2025.more...
As of September 2025 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi...more...
BOARD MEETINGS Company Name : Aadhaar Ventures Ind Date : 20-03-2026